A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
Introduction In 2021, globally, cardiometabolic diseases (CMDs) accounted for 35% of the 1.73 billion disability-adjusted life years (DALYs) attributed to non-communicable diseases. The Healthy Life ...
Objective Unlike several other fields of healthcare, little is known about the size of ‘therapist effects’ on patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results